Avenue Biosciences provides a machine learning-powered protein engineering platform designed to optimize secretory pathways for therapeutic protein manufacturing. The company serves biotechnology and pharmaceutical developers by enhancing the yield, quality, and production of difficult-to-express proteins, biologics, and gene therapies.
Subscribe to see Avenue Biosciences Holding Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Avenue Biosciences Holding Inc is a biotechnology company headquartered in Menlo Park, United States. Its most recent funding round raised $7.4M in November 2025. Xcout tracks 9 named people at Avenue Biosciences Holding Inc, including Tero-Pekka Alastalo (CEO).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for Avenue Biosciences Holding Inc, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Avenue Biosciences Holding Inc's closest competitors — see the full list of competitors and alternatives →
AbInitio Bio is an AI-native operating platform for drug development and manufacturing headquartered in San Francisco, California. Founded in 2026, the privately held company builds software featuring version history, review gates, and accountable approvals for biotech research.
MNDL Bio applies deep learning and host-optimized DNA sequence engineering to solve physical problems that prevent proteins from expressing, thereby helping clients reduce R&D timelines and costs.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Aether Bio is a biotechnology company headquartered in Menlo Park, California, that develops AI-designed molecular machines. Utilizing its Protein Function Model, the company accelerates protein discovery for advanced manufacturing, super materials, and critical mineral processing.
Engine Biosciences is a Singapore-based biotechnology company and venture-creation platform that combines machine learning, computational biology, and laboratory experimentation to discover and develop new medicines. It builds and invests in therapeutic-focused biotech companies, serving pharmaceutical and healthcare markets.
A-Alpha Bio is a synthetic biology and machine learning company that precisely engineers high-impact medicines by measuring millions of protein-protein interactions. Founded in 2017 as a spinout from the University of Washington, the company is based in Seattle.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Avenue Biosciences Holding Inc? Suggest a correction · Work at Avenue Biosciences Holding Inc? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.